Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jackson, MS
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chapel Hill, NC
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of Southern California Medical Group, Inc.
mi
from
Westlake Village, CA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of Southern California Medical Group, Inc.
mi
from
Westlake Village, CA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
National Ophthalmic Research Institute
mi
from
Fort Myers, FL
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
National Ophthalmic Research Institute
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Marietta Eye Clinic
mi
from
Marietta, GA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Marietta Eye Clinic
mi
from
Marietta, GA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Medical Associates Clinic, PC
mi
from
Dubuque, IA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Medical Associates Clinic, PC
mi
from
Dubuque, IA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Elman Retina Group, PA
mi
from
Baltimore, MD
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Elman Retina Group, PA
mi
from
Baltimore, MD
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Mid-America Retina Consultants, P.A.
mi
from
Kansas City, MO
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Mid-America Retina Consultants, P.A.
mi
from
Kansas City, MO
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Consultants
mi
from
Monroeville, PA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Consultants
mi
from
Monroeville, PA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Retina Research Center
mi
from
Austin, TX
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Retina Research Center
mi
from
Austin, TX
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
mi
from
Houston, TX
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Retina Institute of Virginia
mi
from
Richmond, VA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Retina Institute of Virginia
mi
from
Richmond, VA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
East Bay Retina Consultants, Inc.
mi
from
Oakland, CA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
East Bay Retina Consultants, Inc.
mi
from
Oakland, CA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Southern California Desert Retina Consultants, MC
mi
from
Palm Desert, CA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Southern California Desert Retina Consultants, MC
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Florida Retina Consultants
mi
from
Lakeland, FL
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Florida Retina Consultants
mi
from
Lakeland, FL
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Bascom Palmer Eye Institute
mi
from
Miami, FL
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Bascom Palmer Eye Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Magruder Eye Institute
mi
from
Orlando, FL
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Magruder Eye Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Sarasota Retina Institute
mi
from
Sarasota, FL
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Sarasota Retina Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Florida, P.A.
mi
from
Tampa, FL
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Florida, P.A.
mi
from
Tampa, FL
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Thomas Eye Group
mi
from
Sandy Springs, GA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Thomas Eye Group
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
University of Illinois at Chicago Medical Center
mi
from
Chicago, IL
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Paducah Retinal Center
mi
from
Paducah, KY
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Paducah Retinal Center
mi
from
Paducah, KY
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Valley Eye Physicians & Surgeons
mi
from
Ayer, MA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Valley Eye Physicians & Surgeons
mi
from
Ayer, MA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Retinal and Ophthalmic Consultants
mi
from
Northfield, NJ
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Retinal and Ophthalmic Consultants
mi
from
Northfield, NJ
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
MaculaCare
mi
from
New York, NY
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
MaculaCare
mi
from
New York, NY
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Retina-Vitreous Surgeons of Central New York, PC
mi
from
Syracuse, NY
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Retina-Vitreous Surgeons of Central New York, PC
mi
from
Syracuse, NY
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Western Carolina Clinical Research, LLC
mi
from
Asheville, NC
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Western Carolina Clinical Research, LLC
mi
from
Asheville, NC
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Kittner Eye Center
mi
from
Chapel Hill, NC
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Kittner Eye Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Casey Eye Institute
mi
from
Portland, OR
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Casey Eye Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvania Scheie Eye Institute
mi
from
Philadelphia, PA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania Scheie Eye Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Carolina Retina Center
mi
from
Columbia, SC
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Carolina Retina Center
mi
from
Columbia, SC
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Southeastern Retina Associates
mi
from
Chattanooga, TN
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Southeastern Retina Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Southeastern Retina Associates, P.C.
mi
from
Knoxville, TN
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Southeastern Retina Associates, P.C.
mi
from
Knoxville, TN
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Austin Retina Associates
mi
from
Austin, TX
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Austin Retina Associates
mi
from
Austin, TX
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Retina and Vitreous of Texas
mi
from
Houston, TX
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Retina and Vitreous of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of San Antonio
mi
from
San Antonio, TX
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University, Dept. of Ophthalmology
mi
from
Richmond, VA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University, Dept. of Ophthalmology
mi
from
Richmond, VA
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service
mi
from
Madison, WI
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service
mi
from
Madison, WI
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Arizona Retina and Vitreous Consultants
mi
from
Phoenix, AZ
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Arizona Retina and Vitreous Consultants
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
University of Arizona Medical Center/Department of Ophthalmology
mi
from
Tucson, AZ
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
University of Arizona Medical Center/Department of Ophthalmology
mi
from
Tucson, AZ
Click here to add this to my saved trials
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated:  12/31/1969
Atlantis Eye Care
mi
from
Huntington Beach, CA
Anti-VEGF Treatment for Prevention of PDR/DME
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Status: Enrolling
Updated: 12/31/1969
Atlantis Eye Care
mi
from
Huntington Beach, CA
Click here to add this to my saved trials